서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 9 of 9

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2010-06	The prognostic significance of ERCC1, BRCA1, XRCC1, and beta 111-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection Kang, Chang Hyun; Jang, Bo Gun; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Jheon, Sanghoon; Sung, Sook-Whan; Kim, Joo Hyun Lung Cancer, Vol.68 No.3, pp.478-483	DOI
2012-08	Influence of ATM on DNA methyltransferase inhibitor-iduced radioensitization 김진호	view file
2013-06	Differing effects of adjuvant chemotherapy according to BRCA1 nuclear expression in gastric cancer Kim, Jin Won; Cho, Hyun Jin; Kim, Miso; Lee, Kyung-Hun; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Im, Seock-Ah; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.71 No.6, pp.1435-1443	DOI
2013-06	RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib Min, Ahrum; Im, Seock-Ah; Yoon, Young-Kwang; Song, Sang-Hyun; Nam, Hyun-Jin; Hur, Hyung-Seok; Kim, Hwang-Phill; Lee, Kyung-Hun; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O'Connor, Mark J.; Kim, Woo-Ho; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.12 No.6, pp.865-877	DOI
2016-02	유전성 유방암·난소암에서 BRCA1/BRCA2 돌연변이 검출을 위한 차세대 염기서열 분석법의 임상 적용 이승준	view file
2019-05	Prognostic effects of abnormal DNA damage response protein expression in breast cancer Suh, Koung Jin; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Hyojin; Min, Ahrum; Kim, Tae-Yong; Yang, Yaewon; Lee, Han-Byoel; Moon, Hyeong-Gon; Han, Sae-Won; Oh, Do-Youn; Han, Wonshik; Park, In Ae; Noh, Dong-Young; Im, Seock-Ah Breast Cancer Research and Treatment, Vol.175 No.1, pp.117-127	DOI
2019-12	Genistein Inhibits Proliferation of BRCA1 Mutated Breast Cancer Cells: The GPR30-Akt Axis as a Potential Target Kim, Ga Yun; Suh, Jinyoung; Jang, Jeong-Hoon; Kim, Do-Hee; Park, Ock Jin; Park, Sue K.; Surh, Young-Joon 대한암예방학회지, Vol.24 No.4, pp.197-207	DOI
2020-07	Clinicopathological Features of Patients with the BRCA1 c.5339T > C (p.Leu1780Pro) Variant Park, Hyung Seok; Ryu, Jai Min; Park, Ji Soo; Im, Seock-Ah; Jung, So-Youn; Kim, Eun-Kyu; Park, Woo-Chan; Min, Jun Won; Lee, Jeeyeon; You, Ji Young; Lee, Jeong Eon; Kim, Sung-Won Cancer Research and Treatment, Vol.52 No.3, pp.680-688	DOI
2021-10	Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial Lee, Kyung-Hun; Sohn, Joohyuk; Goodwin, Annabel; Usari, Tiziana; Lanzalone, Silvana; Im, Seock-Ah; Kim, Sung-Bae Cancer Research and Treatment, Vol.53 No.4, pp.1084-1095	DOI

1